HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiziana Angusti Selected Research

Radium

4/2023Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis.
12/2022Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiziana Angusti Research Topics

Disease

3Prostatic Neoplasms (Prostate Cancer)
04/2023 - 05/2017
3Neoplasms (Cancer)
05/2017 - 11/2009
1Sjogren's Syndrome (Sjogren Syndrome)
09/2017
1Bone Diseases (Bone Disease)
05/2017
1Carcinoma (Carcinomatosis)
05/2017
1Neoplasm Metastasis (Metastasis)
05/2017
1Pain (Aches)
05/2017

Drug/Important Bio-Agent (IBA)

2RadiumIBA
04/2023 - 12/2022
2Radium-223IBA
04/2023 - 12/2022
1Analgesics (Analgesic Drugs)IBA
12/2022
1AlbuminsIBA
12/2022
1Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link
09/2017
1RadiopharmaceuticalsIBA
05/2017
1AndrogensIBA
05/2017
1Androgen Receptors (Androgen Receptor)IBA
05/2017
1Proteins (Proteins, Gene)FDA Link
11/2009

Therapy/Procedure

3Castration
04/2023 - 05/2017
1Therapeutics
05/2017
1Nephrectomy
07/2012